celastrol has been researched along with bms345541 in 1 studies
Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (bms345541) | Trials (bms345541) | Recent Studies (post-2010) (bms345541) |
---|---|---|---|---|---|
885 | 1 | 741 | 98 | 0 | 63 |
Protein | Taxonomy | celastrol (IC50) | bms345541 (IC50) |
---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 1 | |
Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | 4.54 | |
Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | 3.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Idris, AI; Krishnan, M; Landao-Bassonga, E; Mollat, P; Ralston, SH; Simic, P; Vukicevic, S | 1 |
1 other study(ies) available for celastrol and bms345541
Article | Year |
---|---|
Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Cell Differentiation; Cell Survival; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Female; Humans; I-kappa B Kinase; Imidazoles; Inhibitory Concentration 50; Mice; Osteoclasts; Ovariectomy; Pentacyclic Triterpenes; Quinoxalines; Sesquiterpenes; Signal Transduction; Triterpenes | 2010 |